Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Aug 15;100(4):763–767. doi: 10.1172/JCI119589

Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease.

S E Schutzer 1, P K Coyle 1, L B Krupp 1, Z Deng 1, A L Belman 1, R Dattwyler 1, B J Luft 1
PMCID: PMC508246  PMID: 9259573

Abstract

Lyme disease is the major tick-borne disease, caused by Borrelia burgdorferi (Bb). Neurological involvement is common in all stages. In vivo expression of Bb antigens (Ags) and the immune response to them has not been well investigated in the cerebrospinal fluid (CSF). Upregulation of outer surface protein (Osp) C and concomitant downregulation of OspA before tick inoculation of the spirochete has been reported in skin and blood in animals. CSF OspA Ag in early disease suggests otherwise in CSF. Early Ag expression and IgM response in human CSF was investigated here. Paired CSF and serum was collected from 16 early, predominantly erythema migrans Lyme disease patients with neurologic problems, 13 late Lyme disease patients, and 19 other neurologic disease (OND) controls. Samples were examined for IgM reactivity to recombinant Bb-specific Osps using ELISA and immunoblot. Of 12 early Lyme disease patients with neurologic involvement with both CSF and serum IgM against OspC, 7 (58%) had IgM to OspA (n = 5) or OspB (n = 2) that was restricted to the CSF, not serum. Overall, 12 of 16 (75%) of these early Lyme disease patients with neurologic involvement had CSF and serum IgM against OspC. Only 3 of 13 (23%) late Lyme disease patients and none of 19 OND controls had CSF IgM directed against OspC. In conclusion, in CSF, OspC and OspA can be coexpressed, and IgM response to them occurs in early Lyme disease patients with neurologic involvement. This biologic finding may also provide a discriminating marker for CNS infection in Lyme disease.

Full Text

The Full Text of this article is available as a PDF (164.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akins D. R., Porcella S. F., Popova T. G., Shevchenko D., Baker S. I., Li M., Norgard M. V., Radolf J. D. Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue. Mol Microbiol. 1995 Nov;18(3):507–520. doi: 10.1111/j.1365-2958.1995.mmi_18030507.x. [DOI] [PubMed] [Google Scholar]
  2. Barbour A. G. Plasmid analysis of Borrelia burgdorferi, the Lyme disease agent. J Clin Microbiol. 1988 Mar;26(3):475–478. doi: 10.1128/jcm.26.3.475-478.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bergström S., Bundoc V. G., Barbour A. G. Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi. Mol Microbiol. 1989 Apr;3(4):479–486. doi: 10.1111/j.1365-2958.1989.tb00194.x. [DOI] [PubMed] [Google Scholar]
  4. Champion C. I., Blanco D. R., Skare J. T., Haake D. A., Giladi M., Foley D., Miller J. N., Lovett M. A. A 9.0-kilobase-pair circular plasmid of Borrelia burgdorferi encodes an exported protein: evidence for expression only during infection. Infect Immun. 1994 Jul;62(7):2653–2661. doi: 10.1128/iai.62.7.2653-2661.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Coyle P. K., Deng Z., Schutzer S. E., Belman A. L., Benach J., Krupp L. B., Luft B. Detection of Borrelia burgdorferi antigens in cerebrospinal fluid. Neurology. 1993 Jun;43(6):1093–1098. doi: 10.1212/wnl.43.6.1093. [DOI] [PubMed] [Google Scholar]
  6. Coyle P. K. Neurologic complications of Lyme disease. Rheum Dis Clin North Am. 1993 Nov;19(4):993–1009. [PubMed] [Google Scholar]
  7. Coyle P. K., Schutzer S. E., Belman A. L., Krupp L. B., Golightly M. G. Cerebrospinal fluid immune complexes in patients exposed to Borrelia burgdorferi: detection of Borrelia-specific and -nonspecific complexes. Ann Neurol. 1990 Dec;28(6):739–744. doi: 10.1002/ana.410280603. [DOI] [PubMed] [Google Scholar]
  8. Coyle P. K., Schutzer S. E., Deng Z., Krupp L. B., Belman A. L., Benach J. L., Luft B. J. Detection of Borrelia burgdorferi-specific antigen in antibody-negative cerebrospinal fluid in neurologic Lyme disease. Neurology. 1995 Nov;45(11):2010–2015. doi: 10.1212/wnl.45.11.2010. [DOI] [PubMed] [Google Scholar]
  9. Das S., Barthold S. W., Giles S. S., Montgomery R. R., Telford S. R., 3rd, Fikrig E. Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host. J Clin Invest. 1997 Mar 1;99(5):987–995. doi: 10.1172/JCI119264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dunn J. J., Lade B. N., Barbour A. G. Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA. Protein Expr Purif. 1990 Nov;1(2):159–168. doi: 10.1016/1046-5928(90)90011-m. [DOI] [PubMed] [Google Scholar]
  11. Dvorák J., Janssen B., Grob D. The neurologic workup in patients with cervical spine disorders. Spine (Phila Pa 1976) 1990 Oct;15(10):1017–1022. doi: 10.1097/00007632-199015100-00007. [DOI] [PubMed] [Google Scholar]
  12. Gerber M. A., Shapiro E. D., Bell G. L., Sampieri A., Padula S. J. Recombinant outer surface protein C ELISA for the diagnosis of early Lyme disease. J Infect Dis. 1995 Mar;171(3):724–727. doi: 10.1093/infdis/171.3.724. [DOI] [PubMed] [Google Scholar]
  13. Halperin J. J., Little B. W., Coyle P. K., Dattwyler R. J. Lyme disease: cause of a treatable peripheral neuropathy. Neurology. 1987 Nov;37(11):1700–1706. doi: 10.1212/wnl.37.11.1700. [DOI] [PubMed] [Google Scholar]
  14. Halperin J. J., Volkman D. J., Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology. 1991 Oct;41(10):1571–1582. doi: 10.1212/wnl.41.10.1571. [DOI] [PubMed] [Google Scholar]
  15. Huff J. S., Syverud S. A., Tucci M. A. Case conference: complete heart block in a young man. Acad Emerg Med. 1995 Aug;2(8):751–756. doi: 10.1111/j.1553-2712.1995.tb03631.x. [DOI] [PubMed] [Google Scholar]
  16. Kalish R. A., Leong J. M., Steere A. C. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun. 1993 Jul;61(7):2774–2779. doi: 10.1128/iai.61.7.2774-2779.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Krupp L. B., Masur D., Schwartz J., Coyle P. K., Langenbach L. J., Fernquist S. K., Jandorf L., Halperin J. J. Cognitive functioning in late Lyme borreliosis. Arch Neurol. 1991 Nov;48(11):1125–1129. doi: 10.1001/archneur.1991.00530230033017. [DOI] [PubMed] [Google Scholar]
  18. Lewis L. L., Taber L. H., Baughn R. E. Evaluation of immunoglobulin M western blot analysis in the diagnosis of congenital syphilis. J Clin Microbiol. 1990 Feb;28(2):296–302. doi: 10.1128/jcm.28.2.296-302.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Luft B. J., Steinman C. R., Neimark H. C., Muralidhar B., Rush T., Finkel M. F., Kunkel M., Dattwyler R. J. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA. 1992 Mar 11;267(10):1364–1367. [PubMed] [Google Scholar]
  20. Marconi R. T., Samuels D. S., Garon C. F. Transcriptional analyses and mapping of the ospC gene in Lyme disease spirochetes. J Bacteriol. 1993 Feb;175(4):926–932. doi: 10.1128/jb.175.4.926-932.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Margolis N., Hogan D., Tilly K., Rosa P. A. Plasmid location of Borrelia purine biosynthesis gene homologs. J Bacteriol. 1994 Nov;176(21):6427–6432. doi: 10.1128/jb.176.21.6427-6432.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Montgomery R. R., Malawista S. E., Feen K. J., Bockenstedt L. K. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease. J Exp Med. 1996 Jan 1;183(1):261–269. doi: 10.1084/jem.183.1.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pachner A. R., Duray P., Steere A. C. Central nervous system manifestations of Lyme disease. Arch Neurol. 1989 Jul;46(7):790–795. doi: 10.1001/archneur.1989.00520430086023. [DOI] [PubMed] [Google Scholar]
  24. Pachner A. R., Steere A. C. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology. 1985 Jan;35(1):47–53. doi: 10.1212/wnl.35.1.47. [DOI] [PubMed] [Google Scholar]
  25. Padula S. J., Dias F., Sampieri A., Craven R. B., Ryan R. W. Use of recombinant OspC from Borrelia burgdorferi for serodiagnosis of early Lyme disease. J Clin Microbiol. 1994 Jul;32(7):1733–1738. doi: 10.1128/jcm.32.7.1733-1738.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Padula S. J., Sampieri A., Dias F., Szczepanski A., Ryan R. W. Molecular characterization and expression of p23 (OspC) from a North American strain of Borrelia burgdorferi. Infect Immun. 1993 Dec;61(12):5097–5105. doi: 10.1128/iai.61.12.5097-5105.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schwan T. G., Piesman J., Golde W. T., Dolan M. C., Rosa P. A. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2909–2913. doi: 10.1073/pnas.92.7.2909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Steere A. C., Berardi V. P., Weeks K. E., Logigian E. L., Ackermann R. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis. 1990 Jun;161(6):1203–1209. doi: 10.1093/infdis/161.6.1203. [DOI] [PubMed] [Google Scholar]
  29. Steere A. C. Lyme disease. N Engl J Med. 1989 Aug 31;321(9):586–596. doi: 10.1056/NEJM198908313210906. [DOI] [PubMed] [Google Scholar]
  30. Stiernstedt G. T., Granström M., Hederstedt B., Sköldenberg B. Diagnosis of spirochetal meningitis by enzyme-linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid. J Clin Microbiol. 1985 May;21(5):819–825. doi: 10.1128/jcm.21.5.819-825.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Zhang J. R., Hardham J. M., Barbour A. G., Norris S. J. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell. 1997 Apr 18;89(2):275–285. doi: 10.1016/s0092-8674(00)80206-8. [DOI] [PubMed] [Google Scholar]
  32. de Silva A. M., Telford S. R., 3rd, Brunet L. R., Barthold S. W., Fikrig E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med. 1996 Jan 1;183(1):271–275. doi: 10.1084/jem.183.1.271. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES